Endometriosis Market Outlook 2030 | Endometriosis Market Report 2030

Endometriosis is a disease associated with the abnormal growth of endometrial-like tissue outside the uterus. Endometrial tissue normally lines the uterus and thickens and breaks down as part of the menstrual cycle when a woman is not pregnant. The abnormal growths, or lesions, commonly develop on or around the reproductive organs and on the bowels or bladder, but they can also develop elsewhere.

DelveInsight's "Endometriosis Market Insights, Epidemiology, and Market Forecast 2030" report delivers an in-depth understanding of the Endometriosis, historical and forecasted epidemiology as well as the Endometriosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


Geography Covered

The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan

Read the full report: https://www.delveinsight.com/sample-request/endometriosis-market

Endometriosis Disease Overview

Causes of Endometriosis:

· Retrograde menstruation

· Genetics

· Immune dysfunction

· Environmental factors

· Metaplasia

Stages of Endometriosis:

· Minimal Endometriosis

· Mild Endometriosis

· Moderate Endometriosis

· Severe Endometriosis

The DelveInsight Endometriosis market report gives a thorough understanding of the Endometriosis by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment. 

Click here and get access to free sample copy of the report.

Endometriosis Epidemiology  

According to the Office of Women’s Health, endometriosis may affect more than 11% of American women between 15 and 44 years of age. It is especially common among women in their 30s and 40s and may make it harder to get pregnant.

The Endometriosis epidemiology division provide insights about historical and current Endometriosis patient pool and forecasted trend for every seven major countries.

Key Findings

· As per the Endometriosis News, endometriosis is estimated to affect around 1 in 10 women of reproductive age.

· Additionally, Endometriosis may be present in around 30–50% of women with infertility, as not having given birth is a disease risk factor and infertility is a common disease complication. Though the disease is rare in women who have already been through menopause, but may still develop. It is estimated to occur in around 2–5% of postmenopausal women, though this may include previously undiagnosed cases.

The disease epidemiology covered in the report provides historical as well as forecasted Endometriosis epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030. 

Request to free sample copy of the report: https://www.delveinsight.com/sample-request/endometriosis-market

Endometriosis Drug Chapters

The pipeline of Endometriosis possess few potential key players, such as:

· ObsEva

· Myovant Sciences

· Bayer

· Merck

· Mitsubishi Tanabe Pharma Development America

The dynamics of the Endometriosis market is anticipated to change in the coming years owing to the improvement in the research and development activities so that market will comprise of efficient treatment options.

The launch of emerging therapies is expected during the forecast period of 2021–2030.

Endometriosis Market Outlook

Several approved therapies for the management of endometriosis include Orilissa (AbbVie), Depo-subq Provera 104 (Pfizer), Lupron Depot (AbbVie), Zoladex (AstraZeneca), Synarel (Pfizer), Danocrine (Sanofi), etc.

Additionally, Orilissa and Lupron Depot are gonadotropin-releasing hormone (GnRH) receptor antagonists approved for the management of moderate to severe pain associated with endometriosis while Depo-subQ Provera 104 is a progestin that is indicated in females of reproductive age for prevention of pregnancy as well as management of endometriosis-associated pain.

However, the treatment paradigm of Endometriosis includes the use of simple pain relief medications, hormonal therapy and surgery.

According to DelveInsight, the Endometriosis market in 7MM is expected to change in the study period 2017-2030.

Key Findings

· The United States Market Outlook

· EU-5 Countries: Market Outlook

· Japan Market Outlook 

Visit our repository of reports: https://www.delveinsight.com/report-store.php

 

Comments

Post a Comment

Popular posts from this blog

Tenosynovial Giant Cell Tumors (TSGCTs) Market Research Report 2030 | Tenosynovial Giant Cell Tumors (TSGCTs) Market

Image
Tenosynovial Giant Cell Tumors   are a type of neoplasm that affects synovial-lined tendon sheaths, synovial joints, and surrounding soft tissue. Locally aggressive benign tissue lesions are defined by synovial lining inflammation in joints and tendons. Overexpression of the colony-stimulating factor 1 receptor is thought to cause these tumors to form. Giant cell tumors of the tendon sheath (GCTTS), pigmented villonodular tumors (PVNTS), extra-articular pigmented villonodular tumors of the tendon sheath, and localized or focal nodular synovitis are all terms used to describe TSGCTs. Tenosynovial Giant Cell Tumors Causes Translocation is an alteration to a chromosome that causes Tenosynovial Giant Cell Tumors. A chromosome segment breaks off and moves around. The cause of these translocations is unknown. The genetic code for making proteins is stored on chromosomes. A protein termed colony-stimulating factor 1 is produced in excess due to the translocation (CSF1). This protein attracts
Read more

Functional Dyspepsia Market Research Report 2030 | Functional Dyspepsia Market

Image
  Functional dyspepsia   is a term for recurring signs and symptoms of indigestion that have no apparent cause. Functional dyspepsia is also called non-ulcer stomach pain or non-ulcer dyspepsia. It's not clear what causes functional dyspepsia. Doctors consider it a functional disorder, which means that routine testing may not show any abnormalities. Hence, it is diagnosed based on symptoms. Functional Dyspepsia Signs and Symptoms  Functional dyspepsia is common and can be long-lasting — although signs and symptoms are mostly intermittent. These signs and symptoms resemble those of an ulcer, discomfort in your upper abdomen, often accompanied by bloating, belching, and nausea, An early feeling of fullness (satiety) when eating, Pain in the stomach that may sometimes occur unrelated to meals, or maybe relieved with meals. Functional Dyspepsia Epidemiology According to an article by Madisch et al. (2018), Functional Dyspepsia is one of the common functional disorders, with a prevalenc
Read more

Fibrodysplasia Ossificans Progressiva Market Research Report 2030 | Fibrodysplasia Ossificans Progressiva Market

Image
  Fibrodysplasia ossificans progressiva   is a disorder in which the skeleton, muscles, and connective tissues, such as tendons and ligaments, are replaced by bone (ossified). This position was to lead to the formation of the bones of the skeleton (extra-skeletal or heterotopic bone) that constrains movement. Fibrodysplasia ossificans progressiva Causes Fibrodysplasia ossificans progressiva is called a mutation in the ACVR1 gene. This gene is involved in bone growth and development. Mutations, and the possibility of a disorderly development. The gene can be inherited from a parent, but in most cases, the, is a new mutation, a person with a less-than-a family history of the disease. As a parent, they have a 50% chance of passing it on to their children. Fibrodysplasia ossificans progressiva Sign and Symptoms The  Fibrodysplasia ossificans progressiva  symptoms begin in the first decade of life with episodes of painful inflammatory soft tissue swellings. Gradually, there occurs restricti
Read more